Dr N.M. Raghavendra
Professor
| Department of Pharmaceutical Chemistry
Acharya B M Reddy College of Pharmacy
(2018 - 2025)
Expertise:
Medicinal Chemistry
52
Publications
11
Projects
1204
Scopus Citations
1076
CrossRef
19 Years 4 Months Total Experience
Scopus
1,204
Citations
19
h-index
CrossRef
1,076
Citations
19
h-index
Google Scholar
Loading Scholar statistics...
Professional Recognition
Postdoctoral Fellowship (2015-2018
2015
The Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)-Fiocruz fellowship by the Go
Junior Research Fellowship
2001
All India Council for Technical Education (AICTE)
Silver Jubilee Fund Award
2003
Government College of Pharmacy, Bengaluru, Karnataka
STARS Award 2020 for Teachers for ‘Excellence in Academic Research
2020
American Association of Government College of Pharmacy (Bengaluru) Alumni, New York, USA
Community & Membership
Atal Ranking of Institution on Innovation Achievements (ARIIA) of Acharya & BM Reddy Colle
Nodal OfficerInstitution Innovation Council of Acharya & BM Reddy College of Pharmacy, Bengaluru
Member SecretaryScientific and Industrial Research Organization of Gokaraju Rangaraju Educational Society,
In-ChargeKarnataka State Pharmacy Council
Registered PharmacistIndian Pharmaceutical Association
Life MemberIndian Society for Technical Education
Life MemberAssociation of Pharmaceutical Teachers of India
Life MemberPersonal Details
Doctor of Philosophy
2008
Central Institute of Post Harvest Engineering and Technology
Master of Pharmacy
2003
Institute of Liver and Bilary Sciences
Bachelor of Pharmacy
1999
BrahMos Aerospace
Professor
Jul 2018 – May 2025
Acharya B M Reddy College of Pharmacy
| Department of Pharmaceutical Chemistry
Post-Doctoral Fellow
Sep 2012 – Oct 2013
Purdue University
Professor
Jul 2008 – Jun 2015
Gokaraju Rangaraju College of Pharmacy
| Department of Pharmaceutical Chemistry
Senior Lecturer
Feb 2003 – Jun 2008
Acharya B M Reddy College of Pharmacy
| Department of Pharmaceutical Chemistry
Medical and Health Sciences
Scholarly Work
Discovery of triangular heterocyclic molecules as inhibitors of dual oncogenic pathways triggered by HSP90 and BRAF kinase
OtherDiscovery of trigonal heterocyclic molecules as oncogenic BRAF inhibitors for the treatment of small cell lung carcinoma
OtherMolecular design, chemical synthesis and anticancer studies of tri-substituted heterocyclic compounds as HSP90 inhibitors
OtherEffects of mearnsitrin on doxorubicin induced apoptosis in H9C2 cells
OtherChemical synthesis of novel nicotine analogs
CompletedTo study the disruption of oncogenic HSP90-Client protein interactomes to treat cancer
CompletedUnveiling the novel drugs targeting RAF-MEK-ERK signaling cascade for anti-cancer therapy
CompletedHSP90 chemical and structural proteomics for oncogenic protein target discovery
CompletedDesign and development of Ras/Raf interaction inhibitors
CompletedDesign and development of HSP90 inhibitors
CompletedTools for the design and synthesis of drugs
CompletedPhytochemical and pharmacological studies of Guazuma ulmifolia
Phytochemical and pharmacological evaluation of herbal products for metabolic syndrome
Docking, SAR studies, synthesis & biological evaluation of novel HSP90 inhibitors
No Data Found
There is currently nothing to display here.
Scholarly Publications
Molecular modeling, synthesis and pharmacological evaluation of 1,3,4- Thiadiazoles as anti-inflammatory and analgesic agents
Beyond peptides: Unveiling the design strategies, structure activity correlations and protein-ligand interactions of small molecule inhibitors against PD-1/PD-L1
Unveiling New Avenues in Depression Therapy: In Silico Analysis of Nidus vespae’s Therapeutic Effects
10.1007/s40011-025-01689-6
Scopus: 1
Unlocking nature’s power: exploring phytoremediation for the biodegradation of low-density polyethylene through the application of the phytoconstituents of parboiled Curcuma longa L. rhizome
Novel symmetrical Hantzsch 1,4-dihydropyridines as EGFR inhibitors against breast cancer: Molecular design, synthesis, analysis, in-silico insights, anti-cancer evaluation and EGFR1/HER2 inhibition studies using MCF-7 cells
Design and Development of Novel Glitazones for Activation of PGC-1α Signaling Via PPAR-γ Agonism: A Promising Therapeutic Approach against Parkinson’s Disease
Open AccessDesigning Studies in Pharmaceutical and Medicinal Chemistry
Nonlocal corrections to Fresnel optics: Jellium-model calculations above the bulk-plasmon threshold.
10.1103/physrevb.39.13139
Crossref: 17
Showing 1 to 8 of 52 publications